摘要
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| 貢獻的翻譯標題 | Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody |
|---|---|
| 原文 | English |
| 專利號 | 8535674 |
| 出版狀態 | Published - 1800 |
UN SDG
此研究成果有助於以下永續發展目標
